Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
PHASE1
To explore the safety, efficacy and pharmacokinetic (PK) characteristics of...
Status
Completed
Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
PHASE2
Diarrhoea is the most commonly reported adverse event (AE) associated with ...